CClinicalTrials.gg
Status unknownNCT04314960ESCAIPUpdated Sep 2, 2020

Functional Electrical Stimulation in Chronic Ankle Instability

An interventional study of Functional electrical stimulation device (NESS L300Plus, Bioness, Valencia, CA) in Joint Instability, Ankle Sprains and Sport Injury, sponsored by Shmuel Springer. Status unknown at 1 site in Israel. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-09-02.

Sponsored by Shmuel Springer · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Sep 2020), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
22
Allocation
Not applicable
Ages
18 Years to 45 Years
Sex
All
01

Study summary

Individuals with chronic ankle instability (CAI) display neuromuscular deficits such as altered control of posture and gait when compared with healthy controls. These deficits may be attributed to muscle inhibition occurring after a surrounding joint structure has been damaged. Functional electrical stimulation (FES) is the application of high-intensity intermittent electrical stimuli to generate muscle contractions that may overcome inhibition, and which is coupled with a functional task such as gait.

The current study aims to investigate the short and immediate effects of FES on gait parameters and postural control in subjects with CAI. Prior to intervention, treadmill gait will be evaluated using a motion analysis system, and postural control will be evaluated in a series of tests that measure balance, reaction time to ankle perturbation and stabilization ability after jump-landing. Then, a 20 minutes gait training with an FES device will be applied. Immediate effects of the training on gait parameters will be assessed. For medium-term effects evaluation, subjects will return for additional 7 training sessions (2 per week for 4 weeks), following by a complete measurements acquisition as prior to intervention. At six months follow-up, subjects will be contacted for collecting subjective outcomes.

02

Conditions studied

  • Joint Instability
  • Ankle Sprains
  • Sport Injury

Keywords

  • Chronic ankle instability
  • Rehabilitation
  • Neuromuscular control
  • Gait
  • Electrical stimulation
03

In context

Joint Instability

147 studies on the registry are indexed under Joint Instability; 22 are open to participants now.

This study's planned enrollment of 22 is below the median of 42 across 80 interventional studies indexed under Joint Instability.

Browse Joint Instability studies →

Lead sponsor

This is the only study on the registry with Shmuel Springer as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. A history of at least one significant ankle sprain:

    1. At least 12 months prior to participating in the study
    2. Was characterized by inflammatory symptoms (i.e. pain and swelling)
    3. Caused at least one day of decreased physical activity
  2. At least 3 months since the last acute ankle sprain that results in inflammatory symptoms and at least one interrupted day of desired physical activity.
  3. History of the previously injured ankle 'giving way' at least twice during the last 6 months, and/or 'feelings of instability' and/or recurrent sprain.
  4. Being able to bear full weight on the injured lower extremity with no more than mild discomfort.
  5. Scoring\<24 in the Cumberland Ankle Instability Tool (CAIT)

Exclusion criteria

Exclusion Criteria:

  1. A history of previous surgeries to a musculoskeletal structure in either lower limb.
  2. A history of a fracture requiring re-alignment
  3. Any acute injury to a lower limb in the last 3 months.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
22 participants (estimated)

Study arms

  • Experimental
    CAI subjects

    Subjects in this group will receive eight 20-minutes gait training sessions with functional electrical stimulation.

    Device: Functional electrical stimulation device (NESS L300Plus, Bioness, Valencia, CA)

Interventions

  • DeviceFunctional electrical stimulation device (NESS L300Plus, Bioness, Valencia, CA)

    Functional electrical stimulation (FES) is the application of high-intensity intermittent electrical stimuli to generate muscle contractions that may bypass spinal and supraspinal inhibition, and which is coupled with a functional task such as gait. Gait training will be conducted on a treadmill.

06

What researchers measure

Primary outcomes

  1. Immediate change in ankle inversion angle during heel strike

    Ankle inversion angle at heel strike (in degrees) will be measured using Qualisys motion analysis system. Change will be measured between pre-intervention to immediately after first intervention session to assess immediate effects of the intervention.

    Time frame: immediately after the intervention

  2. Change in ankle inversion angle during heel strike at 4 weeks

    Ankle inversion angle at heel strike (in degrees) will be measured using Qualisys motion analysis system. Change will be measured between pre-intervention and after completing the entire intervention.

    Time frame: through intervention completion, approximately at 4 weeks

  3. Immediate change in peroneal muscle electromyography

    Peroneal muscle activity will be measured (in millivolts) using Trigno EMG system during the 5% of gait cycle prior to heel strike. Change will be measured between pre-intervention to immediately after first intervention session to assess immediate effects of the intervention.

    Time frame: immediately after the intervention

  4. Change in peroneal muscle electromyography at 4 weeks

    Peroneal muscle activity will be measured (in millivolts) using Trigno EMG system during the 5% of gait cycle prior to heel strike. Change will be measured between pre-intervention and after completing the entire intervention.

    Time frame: through intervention completion, approximately at 4 weeks

Secondary outcomes

  1. Change in Star excursion balance test (SEBT) score

    The SEBT has been previously described as a postural control test that can differ between subjects with CAI and healthy controls. The test is performed with the subjects standing barefoot in the middle of a grid formed by eight tape measures extending out at 45° from each other. While the subject is balancing on one leg that is placed in the middle of the grid, the other leg has to reach as far as possible in each direction. The reached distance in centimeters is recorded, with the greater distance representing better postural stability. An average scores is calculated and normalized to the length of the subject's leg in centimeters.

    Time frame: through intervention completion, approximately at 4 weeks

  2. Time to stabilization (TTS)

    TTS is the time required to normalize ground reaction forces (GRF) after following a jump-landing. To measure TTS, subjects will be required to perform a single-leg drop-jump from a 40-cm box onto a force plate (Kistler, Switzerland) and keep balancing on a single leg for 20 seconds. GRF recordings will be analyzed to determine TTS in seconds in the ML and AP planes, as was previously described. Shorter duration demonstrates better postural stability. Subjects will be allowed at least 3 practice trials, following by 5 successful jumps landings. A rest period of 30 seconds will be allowed between jumps. If a subject will not be able to stabilize for at least 20 seconds, the trial will be repeated. Lower values indicate better postural control.

    Time frame: through intervention completion, approximately at 4 weeks

  3. Peroneal reaction time (PRT)

    PRT is the time duration between and ankle inversion perturbation and beginning of peroneal muscle activation which is recognized using EMG. Subjects will stand on an inversion stimulator. In an unknown time, a sudden inversion perturbation will occur. Time measurement between perturbation time and muscle activation time is measured in seconds. Lower values indicate better postural control.

    Time frame: through intervention completion, approximately at 4 weeks

Other outcomes

  1. Foot and Ankle Ability Measure (FAAM) - questionnaire

    A self-reported functional outcome measure utilized to track subjective changes in perceived pain and ankle function Score ranges between 0-100. Higher scores represent higher levels of function, with score of 100 represents no disability.

    Time frame: through intervention completion, approximately at 4 weeks

  2. Cumberland Ankle Instability Tool (CAIT) - questionnaire

    A self-reported outcome measure designated for people with chronic ankle instability. Will also serve as an inclusion criteria. Score ranges between 0-30, with lower scores indicate less ankle instability.

    Time frame: through intervention completion, approximately at 4 weeks

07

Study locations

1 of 1 sites recruiting
  • Ariel University
    Ariel, 40700, Israel
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — Not decided yet, but optional to share all data after concealing subject's identifying details.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 2, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04314960
Lead sponsor
Shmuel Springer
Responsible party
Shmuel Springer (Chair, Physiotherapy Department, Neuromuscular & Human Performance Laboratory, Ariel University) — Sponsor-investigator
First posted
Mar 19, 2020
Start date
Jun 23, 2020
Primary completion
Jun 2022 (estimated)
Completion
Jun 2022 (estimated)
Last update
Sep 2, 2020

Study contacts

Uri Gottlieb, MSc
Contact
urigott@gmail.com
+972542022767
Shmuel Springer, PhD
principal investigator · Ariel University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion